Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Bram L. T. Ramaekers*, Rob Riemsma, Florian Tomini, Thea van Asselt, Sohan Deshpande, Steven Duffy, Nigel Armstrong, Johan L. Severens, Jos Kleijnen, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)191-202
Number of pages12
JournalPharmacoeconomics
Volume35
Issue number2
DOIs
Publication statusPublished - Feb 2017

Keywords

  • PLACEBO-CONTROLLED PHASE-3
  • SURVIVAL ANALYSIS
  • DOUBLE-BLIND

Cite this

@article{0061397db34342a58428b803185c3bdf,
title = "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal",
keywords = "PLACEBO-CONTROLLED PHASE-3, SURVIVAL ANALYSIS, DOUBLE-BLIND",
author = "Ramaekers, {Bram L. T.} and Rob Riemsma and Florian Tomini and {van Asselt}, Thea and Sohan Deshpande and Steven Duffy and Nigel Armstrong and Severens, {Johan L.} and Jos Kleijnen and Joore, {Manuela A.}",
year = "2017",
month = "2",
doi = "10.1007/s40273-016-0445-5",
language = "English",
volume = "35",
pages = "191--202",
journal = "Pharmacoeconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "2",

}

Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer : An Evidence Review Group Perspective of an NICE Single Technology Appraisal. / Ramaekers, Bram L. T.; Riemsma, Rob; Tomini, Florian; van Asselt, Thea; Deshpande, Sohan; Duffy, Steven; Armstrong, Nigel; Severens, Johan L.; Kleijnen, Jos; Joore, Manuela A.

In: Pharmacoeconomics, Vol. 35, No. 2, 02.2017, p. 191-202.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

T2 - An Evidence Review Group Perspective of an NICE Single Technology Appraisal

AU - Ramaekers, Bram L. T.

AU - Riemsma, Rob

AU - Tomini, Florian

AU - van Asselt, Thea

AU - Deshpande, Sohan

AU - Duffy, Steven

AU - Armstrong, Nigel

AU - Severens, Johan L.

AU - Kleijnen, Jos

AU - Joore, Manuela A.

PY - 2017/2

Y1 - 2017/2

KW - PLACEBO-CONTROLLED PHASE-3

KW - SURVIVAL ANALYSIS

KW - DOUBLE-BLIND

U2 - 10.1007/s40273-016-0445-5

DO - 10.1007/s40273-016-0445-5

M3 - Review article

VL - 35

SP - 191

EP - 202

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 2

ER -